This 2017 study examines the market penetration of non-quality-assured artemisinin combination therapy (ACT) across eight African countries to assess quality.

Share Article

Related Publications

Search All Publications

Browse the full Publication Library — filter by impact area, resource type, year and collection to find what you need.